Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Convalescent plasma is a leading treatment for coronavirus disease 2019 (COVID-19), but there is a paucity of data identifying its therapeutic efficacy. Among 126 potential convalescent plasma donors, the humoral immune response was evaluated using a severe acute respiratory syndrome coronavirus 2 (...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:J Clin Invest
Główni autorzy: Klein, Sabra L., Pekosz, Andrew, Park, Han-Sol, Ursin, Rebecca L., Shapiro, Janna R., Benner, Sarah E., Littlefield, Kirsten, Kumar, Swetha, Naik, Harnish Mukesh, Betenbaugh, Michael J., Shrestha, Ruchee, Wu, Annie A., Hughes, Robert M., Burgess, Imani, Caturegli, Patricio, Laeyendecker, Oliver, Quinn, Thomas C., Sullivan, David, Shoham, Shmuel, Redd, Andrew D., Bloch, Evan M., Casadevall, Arturo, Tobian, Aaron A.R.
Format: Artigo
Język:Inglês
Wydane: American Society for Clinical Investigation 2020
Hasła przedmiotowe:
Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7598041/
https://ncbi.nlm.nih.gov/pubmed/32764200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI142004
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy